Yüksek Doz Tedavi Sonrasında Nükseden Testis Kanserli Bir Hastada Gemsitabin ve Paklitaksel Kurtarma Tedavisi
PDF
Cite
Share
Request
VOLUME: 42 ISSUE: 3
P: 132 - 134
2009

Yüksek Doz Tedavi Sonrasında Nükseden Testis Kanserli Bir Hastada Gemsitabin ve Paklitaksel Kurtarma Tedavisi

Acta Haematol Oncol Turc 2009;42(3):132-134
1. SB Dr. Abdurrahman Yurtarslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Kliniği,
2. SB Dr. Abdurrahman Yurtarslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Radyoloji Kliniği, ANKARA
3.
No information available.
No information available
Received Date: 2014-08-28T17:06:35
PDF
Cite
Share
Request

Abstract

The majority of patients vvith metastatic non-seminomatous germ celi tumors can be cured by cisplatin based combination chemotherapy. Hovvever, patients vvhose condition is cisptatin-refractory or who have recurrence after high dose chemotherapy have vvorse prognosis. We presented here, a 25 years old male patients was diagnosed metastatic embriyonaI testicular carcinoma. The patients received bleomycin, etoposide, cisplatin (BEP) regimen as first line chemotherapy. He experienced early brain relaps and as second line chemotherapy vinblastine, ifosfamide, cisplatin (VeİP) therapy was used. He undervvent high dose chemotherapy vvith peripheric stem celi rescue. For the patient experienced a second recurrence, gemcitabine and pacli-taxel was administered as salvage chemotherapy. He is alive and is free from disease at 30 months.

Keywords:
Testicular cancer, gemcitabine, paclitaxel, salvage treatment.